NewEdge Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $67.1K | Buy |
442
+4
| +0.9% | +$607 | ﹤0.01% | 2574 |
|
|
2025
Q1 | $65.9K | Sell |
438
-86
| -16% | -$12.9K | ﹤0.01% | 2449 |
|
|
2024
Q4 | $96.7K | Sell |
524
-122
| -19% | -$22.5K | ﹤0.01% | 2290 |
|
|
2024
Q3 | $127K | Sell |
646
-1,668
| -72% | -$329K | ﹤0.01% | 2122 |
|
|
2024
Q2 | $478K | Sell |
2,314
-1,025
| -31% | -$212K | ﹤0.01% | 1447 |
|
|
2024
Q1 | $905K | Buy |
3,339
+812
| +32% | +$220K | 0.01% | 1047 |
|
|
2023
Q4 | $553K | Buy |
2,527
+469
| +23% | +$103K | 0.01% | 1229 |
|
|
2023
Q3 | $403K | Buy |
2,058
+206
| +11% | +$40.4K | ﹤0.01% | 1281 |
|
|
2023
Q2 | $389K | Buy |
1,852
+92
| +5% | +$19.3K | ﹤0.01% | 1317 |
|
|
2023
Q1 | $355K | Buy |
1,760
+474
| +37% | +$95.7K | ﹤0.01% | 1293 |
|
|
2022
Q4 | $263K | Buy |
+1,286
| New | +$263K | 0.01% | 1069 |
|
|
2022
Q1 | – | Sell |
-2,670
| Closed | -$1.01M | – | 1240 |
|
|
2021
Q4 | $1.01M | Sell |
2,670
-1,634
| -38% | -$616K | 0.02% | 729 |
|
|
2021
Q3 | $1.78M | Buy |
4,304
+786
| +22% | +$324K | 0.04% | 345 |
|
|
2021
Q2 | $1.3M | Buy |
+3,518
| New | +$1.3M | 0.03% | 413 |
|
|
2017
Q3 | – | Sell |
-22
| Closed | -$2.18K | – | 507 |
|
|
2017
Q2 | $2.18K | Buy |
+22
| New | +$2.18K | ﹤0.01% | 1292 |
|